HIGHLIGHTS
- who: Martin Pool from the Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands have published the research: 89Zr-Onartuzumab PET imaging of c-MET receptor dynamics, in the Journal: (JOURNAL)
- what: HCC827 tumours in this study showed high contrast and c-MET-specific 89Zr-onartuzumab uptake at a tracer protein dose of 10 μg.
- how: For ease of clinical translation the authors selected the therapeutic antibody-based PET tracer 89 Zr-onartuzumab which has been reported to effectively discriminate cMET expression in human gastric cancer xenografts .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.